Table 1.
Demographic and pathologic characteristics of 50 control subjects and 100 patients with gastric cancer.
| Variables | No. | Total No. | |
|---|---|---|---|
| Control group | |||
| Age (year) | Mean (range) | 63·5 (25–91) | 50 |
| Gender | F | 38 | 50 |
| M | 12 | ||
| CEA (ng/ml) | Mean (SD) | 1·9 (1·1) | 50 |
| CA19–9 (ng/ml) | Mean (SD) | 20·4 (32·8) | 36 |
| Missing | 14 | ||
| CA72–4 (ng/ml) | Mean (SD) | 2·2 (1·6) | 17 |
| Missing | 33 | ||
| GC group | |||
| Age (year) | Mean (range) | 70·6 (30–92) | 100 |
| Gender | F | 41 | 100 |
| M | 59 | ||
| CEA (ng/ml) | Mean (SD)_Pre | 40·1 (96·1) | 97 |
| Mean (SD)_Post | 13·7 (259·7) | ||
| missing | 3 | ||
| CA19–9 (ng/ml) | Mean (SD)_Pre | 261.6 (1024.4) | 97 |
| Mean (SD)_Post | 93.1 (490.1) | ||
| missing | 3 | ||
| CA72–4 (ng/ml) | Mean (SD)_Pre | 34.3 (143.9) | 90 |
| Mean (SD)_Post | 25.2 (116.5) | ||
| missing | 10 | ||
| Blood type ABO | A | 42 | 94 |
| B | 11 | ||
| O | 38 | ||
| AB | 3 | ||
| Missing | 6 | ||
| Blood type Rh | Rh- | 10 | 94 |
| Rh+ | 84 | ||
| missing | 6 | ||
| Stomach cancer history | No | 84 | 99 |
| Yes | 15 | ||
| missing | 1 | ||
| MSI status | Stable | 63 | 98 |
| High | 35 | ||
| missing | 2 | ||
| Tumour diameter | <50 mm | 30 | 98 |
| ≥50 mm | 68 | ||
| missing | 2 | ||
| TNM stage | I | 8 | 99 |
| II | 20 | ||
| III | 57 | ||
| IV | 14 | ||
| missing | 1 | ||
| Tumour relapse | No | 29 | 65 |
| Yes | 36 | ||
| missing | 35 | ||
MSI: microsatellite instability; EBV: epstein-barr virus.